Industry news
FTC clears Pfizer takeover of Hospira
Pfizer Inc. has announced that the U.S. Federal Trade Commission terminated the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, with respect to Pfizer�s pending acquisition of Hospira. The FTC�s clearance is contingent upon Pfizer�s commitment to divest four U.S. sterile injectable assets, including Acetylcysteine, Clindamycin, Voriconazole and Melphalan. In addition, Pfizer announced that Brazil�s Superintendency-General of CADE has published its unconditional clearance decision.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
